U.S. Interactive Media and Services Stock News

Some Cipher Digital Inc. ( NASDAQ:CIFR ) shareholders may be a little concerned to see that the Independent Director...

High inflation risks, sticky interest rates and energy driven cost pressures have pushed many investors toward income they can see and touch. That is where the Dividend Fortresses screener comes in, focusing on stocks with dividend yields above 5% that aim to offer both resilience and meaningful cash payouts. Instead of trying to guess the next macro twist, you can look at companies that already return a high share of cash to shareholders. In this article you will see three stocks from the...

Tradeweb Markets overview and recent share performance Tradeweb Markets (TW) operates electronic marketplaces across fixed income, equities, and money markets. Its stock has recently drawn attention after a period in which returns have moved differently across time frames. Over the past month, the stock is down about 11%, and down roughly 5% over the past 3 months, while the year to date return is a gain of about 3%. Looking back one year, the total return has fallen about 21%, compared with...

Patria Investments Limited ( NASDAQ:PAX ) stock is about to trade ex-dividend in three days. The ex-dividend date is...

Gold Royalty (GROY) has attracted attention after reporting first quarter 2026 earnings with sales of US$7.18 million and net income of US$1.77 million, a shift from a loss in the prior year period. See our latest analysis for Gold Royalty. The share price sits at US$3.73, with a 7 day share price return of 5.97% and a 90 day share price return that is down 11.19%. The 1 year total shareholder return of 152.03% indicates strong longer term momentum despite recent volatility and follows...

In early May 2026, Syndax Pharmaceuticals reported first-quarter 2026 revenue of US$64.86 million and a net loss of US$42.67 million, while also highlighting 12 Revuforj (revumenib) abstracts accepted for presentation at the June 2026 European Hematology Association Congress that showcase activity across multiple acute leukemia settings and genetic subtypes. An important angle for investors is the breadth of real-world and combination data for Revuforj, including post-transplant maintenance...

Recent performance snapshot Danaos (NYSE:DAC) has attracted fresh attention after recent share price moves, with the stock showing gains over the past month and past 3 months that stand out against its longer term performance profile. With a market value of about US$2.4b and reported revenue of US$1,042.847m alongside net income of US$519.888m, the company’s current pricing invites closer inspection of how investors are weighing its earnings power and risks. See our latest analysis for...

BioCryst Pharmaceuticals (NasdaqGS:BCRX) has granted Neopharmed Gentili exclusive European licensing rights to navenibart for hereditary angioedema. The agreement includes an upfront payment and potential future milestone payments to BioCryst. Neopharmed Gentili is expected to use its existing European commercial infrastructure to support the rollout of navenibart. At ISPOR 2026, BioCryst presented real world evidence on pediatric hereditary angioedema highlighting ongoing medical and...

Bruker Corporation recently reported first-quarter 2026 results, with sales rising to US$823.4 million from US$801.4 million a year earlier, while net income eased to US$14.4 million, and it reconfirmed full-year 2026 revenue guidance of US$3.57 billion to US$3.60 billion. The combination of higher quarterly sales but lower earnings, alongside unchanged full-year revenue expectations, highlights how Bruker is balancing growth investments and cost pressures as it enters the rest of 2026. We...

Harmony Biosciences Holdings, Inc.'s ( NASDAQ:HRMY ) earnings announcement last week didn't impress shareholders...

If you are wondering whether Public Service Enterprise Group (PEG) stock still offers solid value at current levels, it helps to start with how its recent price and fundamentals line up. The share price closed at US$77.22, with returns that declined 2.7% over the past week and 5.0% over the past month, while sitting up 3.1% over 1 year and 47.2% over 5 years. These figures can influence how investors view both upside potential and risk. Recent news coverage has focused on PEG as a large...

Archer-Daniels-Midland (ADM) is back in focus after better-than-expected Q1 2026 profitability and a higher full-year adjusted EPS outlook, supported by stronger soybean crush, improved ethanol margins, and a recovering Nutrition segment. See our latest analysis for Archer-Daniels-Midland. The Q1 earnings beat and higher full-year guidance have coincided with a sharp pick up in momentum, with a 30-day share price return of 18.7% and year-to-date share price return of 40.4%. In addition, the...

Investors may wish to note that the Independent Chairman of Alpine Income Property Trust, Inc. , Andrew Richardson...

Moody’s Corporation recently highlighted contrasting views on its long-term resilience to AI disruption, alongside a past appearance by CEO Rob Fauber at the Bernstein Strategic Decisions Conference, where his remarks were broadcast via a live webcast for investors. Together with fresh research arguing Moody’s long-established ratings moat is relatively insulated from AI, and mixed sentiment signals around its shares, these developments are drawing renewed attention to how technology and...

Why PHINIA’s latest hydrogen milestone matters for stock watchers PHINIA (PHIN) is in focus after debuting its first homologated hydrogen internal combustion light commercial vehicle with Aramco at ACT Expo, while analyst earnings expectations for the company have recently been revised upward. This combination of product progress in lower carbon transportation and shifting earnings expectations provides additional information to consider when looking at how PHINIA’s stock trades today,...

Leidos Holdings (NYSE:LDOS) has been awarded a U.S. Army contract worth up to $2.7b to move hypersonic weapons programs toward production. The award consolidates several advanced hypersonic efforts under a single umbrella, aimed at accelerating development and deployment. The contract supports the company’s NorthStar 2030 vision by expanding its role in high-priority national defense work. For investors watching Leidos at a share price of $124.17, this hypersonics award arrives after a...

It's shaping up to be a tough period for Metagenomi Therapeutics, Inc. ( NASDAQ:MGX ), which a week ago released some...

Klaviyo (NYSE:KVYO) has launched a deeper integration with Anthropic's Claude through a new Model Context Protocol connector. The update allows marketers to use natural language inside Claude to pull Klaviyo first party data, generate campaigns, and automate multi step workflows. This moves Klaviyo's AI tools from insight generation into direct execution across reporting and campaign creation. Klaviyo is rolling out this Claude integration at a time when the stock is trading at $14.24 and...

The market was pleased with the recent earnings report from GoodRx Holdings, Inc. ( NASDAQ:GDRX ), despite the profit...

Taboola.com Ltd. ( NASDAQ:TBLA ) recently posted some strong earnings, and the market responded positively. We did some...

It's been a good week for HF Foods Group Inc. ( NASDAQ:HFFG ) shareholders, because the company has just released its...

DocGo Inc. ( NASDAQ:DCGO ) shareholders are probably feeling a little disappointed, since its shares fell 5.5% to...

CarGurus, Inc.'s ( NASDAQ:CARG ) earnings announcement last week was disappointing for investors, despite the decent...

As you might know, National Energy Services Reunited Corp. ( NASDAQ:NESR ) just kicked off its latest first-quarter...